386 related articles for article (PubMed ID: 23197570)
21. Heparin is essential for optimal cell signaling by FGF21 and for regulation of βKlotho cellular stability.
An SJ; Mohanty J; Tome F; Suzuki Y; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2219128120. PubMed ID: 36745784
[TBL] [Abstract][Full Text] [Related]
22. Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects.
Ying L; Wang L; Guo K; Hou Y; Li N; Wang S; Liu X; Zhao Q; Zhou J; Zhao L; Niu J; Chen C; Song L; Hou S; Kong L; Li X; Ren J; Li P; Mohammadi M; Huang Z
Nat Commun; 2021 Dec; 12(1):7256. PubMed ID: 34907199
[TBL] [Abstract][Full Text] [Related]
23. The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions.
Kilkenny DM; Rocheleau JV
Vitam Horm; 2016; 101():17-58. PubMed ID: 27125737
[TBL] [Abstract][Full Text] [Related]
24. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.
Ding X; Boney-Montoya J; Owen BM; Bookout AL; Coate KC; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2012 Sep; 16(3):387-93. PubMed ID: 22958921
[TBL] [Abstract][Full Text] [Related]
25. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
26. Dynamics and Distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex.
Ming AY; Yoo E; Vorontsov EN; Altamentova SM; Kilkenny DM; Rocheleau JV
J Biol Chem; 2012 Jun; 287(24):19997-20006. PubMed ID: 22523080
[TBL] [Abstract][Full Text] [Related]
27. The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21.
Gupte J; Yang L; Wu X; Weiszmann J; Hecht R; Lemon B; Lindberg R; Wang Z; Li Y
J Mol Biol; 2011 May; 408(3):491-502. PubMed ID: 21392510
[TBL] [Abstract][Full Text] [Related]
28. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling.
Yie J; Wang W; Deng L; Tam LT; Stevens J; Chen MM; Li Y; Xu J; Lindberg R; Hecht R; Véniant M; Chen C; Wang M
Chem Biol Drug Des; 2012 Apr; 79(4):398-410. PubMed ID: 22248288
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
Weng Y; Chabot JR; Bernardo B; Yan Q; Zhu Y; Brenner MB; Vage C; Logan A; Calle R; Talukdar S
PLoS One; 2015; 10(3):e0119104. PubMed ID: 25790234
[TBL] [Abstract][Full Text] [Related]
30. Fasting decreases plasma FGF21 in obese subjects and the expression of FGF21 receptors in adipose tissue in both lean and obese subjects.
Nygaard EB; Ørskov C; Almdal T; Vestergaard H; Andersen B
J Endocrinol; 2018 Oct; 239(1):73–80. PubMed ID: 30307155
[TBL] [Abstract][Full Text] [Related]
31. Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.
Kruse R; Vienberg SG; Vind BF; Andersen B; Højlund K
Diabetologia; 2017 Oct; 60(10):2042-2051. PubMed ID: 28721439
[TBL] [Abstract][Full Text] [Related]
32. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
33. A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects.
Talukdar S; Zhou Y; Li D; Rossulek M; Dong J; Somayaji V; Weng Y; Clark R; Lanba A; Owen BM; Brenner MB; Trimmer JK; Gropp KE; Chabot JR; Erion DM; Rolph TP; Goodwin B; Calle RA
Cell Metab; 2016 Mar; 23(3):427-40. PubMed ID: 26959184
[TBL] [Abstract][Full Text] [Related]
34. Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies.
Antonellis PJ; Kharitonenkov A; Adams AC
J Anim Sci; 2014 Feb; 92(2):407-13. PubMed ID: 24398833
[TBL] [Abstract][Full Text] [Related]
35. Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody.
Huang J; Ishino T; Chen G; Rolzin P; Osothprarop TF; Retting K; Li L; Jin P; Matin MJ; Huyghe B; Talukdar S; Bradshaw CW; Palanki M; Violand BN; Woodnutt G; Lappe RW; Ogilvie K; Levin N
J Pharmacol Exp Ther; 2013 Aug; 346(2):270-80. PubMed ID: 23720456
[TBL] [Abstract][Full Text] [Related]
36. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B
Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744
[TBL] [Abstract][Full Text] [Related]
37. A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys.
Stanislaus S; Hecht R; Yie J; Hager T; Hall M; Spahr C; Wang W; Weiszmann J; Li Y; Deng L; Winters D; Smith S; Zhou L; Li Y; Véniant MM; Xu J
Endocrinology; 2017 May; 158(5):1314-1327. PubMed ID: 28324011
[TBL] [Abstract][Full Text] [Related]
38. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys.
Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P
Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039
[TBL] [Abstract][Full Text] [Related]
39. FGF19 subfamily members: FGF19 and FGF21.
Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
